• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血栓素B2抑制大鼠离体灌注肺对前列腺素E2的灭活作用。

Thromboxane B2 inhibits prostaglandin E2 inactivation by the rat isolated perfused lung.

作者信息

Boura A L, Murphy R D

出版信息

Clin Exp Pharmacol Physiol. 1978 Jul-Aug;5(4):387-92. doi: 10.1111/j.1440-1681.1978.tb00688.x.

DOI:10.1111/j.1440-1681.1978.tb00688.x
PMID:699382
Abstract
  1. The effect of thromboxane B2 (TxB2) on inactivation of prostaglandin E2 (PGE2) by the rat isolated perfused lung has been studied. 2. TxB2 when infused in low concentrations (100 ng/ml) into the pulmonary artery reduced PGE2 inactivation approximately two-fold. 3. The rat isolated fundus strip was contracted by higher concentrations of TxB2 (1.0 microgram/ml) in the presence of hyoscine, mepyramine, methysergide, phenoxybenzamine and propranolol. The size of contraction was reduced by indomethacin in concentrations known to inhibit prostaglandin synthetase. 4. Thus, in circumstances in which TxB2 and PGE2 are released concomitantly by the lung, low concentrations of TxB2 may augment PGE2 release by reducing its inactivation.
摘要
  1. 研究了血栓素B2(TxB2)对大鼠离体灌注肺灭活前列腺素E2(PGE2)的影响。2. 当以低浓度(100 ng/ml)注入肺动脉时,TxB2使PGE2灭活减少约两倍。3. 在存在东莨菪碱、甲氧苄胺嘧啶、甲基麦角新碱、酚苄明和普萘洛尔的情况下,较高浓度(1.0微克/毫升)的TxB2使大鼠离体胃底条收缩。已知抑制前列腺素合成酶的吲哚美辛浓度可使收缩幅度减小。4. 因此,在肺同时释放TxB2和PGE2的情况下,低浓度的TxB2可能通过减少其灭活来增加PGE2的释放。

相似文献

1
Thromboxane B2 inhibits prostaglandin E2 inactivation by the rat isolated perfused lung.血栓素B2抑制大鼠离体灌注肺对前列腺素E2的灭活作用。
Clin Exp Pharmacol Physiol. 1978 Jul-Aug;5(4):387-92. doi: 10.1111/j.1440-1681.1978.tb00688.x.
2
Tromboxane B2 inhibits the pulmonary inactivation of prostaglandin E2 in the dog.血栓素B2抑制犬体内前列腺素E2的肺部失活。
Br J Pharmacol. 1980 Oct;70(2):295-9. doi: 10.1111/j.1476-5381.1980.tb07935.x.
3
Effects of vasoactive intestinal polypeptide on antigen-induced bronchoconstriction and thromboxane release in guinea-pig lung.血管活性肠肽对豚鼠肺中抗原诱导的支气管收缩和血栓素释放的影响。
Br J Pharmacol. 1993 May;109(1):243-50. doi: 10.1111/j.1476-5381.1993.tb13560.x.
4
Thromboxane B2 (TxB2) metabolism in rat isolated lung and its inhibition by drugs.大鼠离体肺中血栓素B2(TxB2)的代谢及其药物抑制作用。
Prostaglandins Leukot Med. 1983 Mar;10(3):221-9. doi: 10.1016/0262-1746(82)90079-8.
5
Thromboxane B2 and prostaglandin E2 in the rat kidney with unilateral ureteral obstruction.单侧输尿管梗阻大鼠肾脏中的血栓素B2和前列腺素E2
Am J Physiol. 1982 Mar;242(3):F220-5. doi: 10.1152/ajprenal.1982.242.3.F220.
6
Thromboxane B2 inhibits the pulmonary metabolism of PGE2 in the anesthetized dog.血栓素B2抑制麻醉犬体内前列腺素E2的肺代谢。
Adv Prostaglandin Thromboxane Res. 1980;7:981-3.
7
Thromboxane B2 and prostaglandin E2 in the K+-depleted rat kidney.低钾血症大鼠肾脏中的血栓素B2和前列腺素E2。
Am J Physiol. 1981 Feb;240(2):F151-7. doi: 10.1152/ajprenal.1981.240.2.F151.
8
Thromboxane B2: a cardiodepressant of isolated rat hearts and inhibitor of sarcolemma Na+ - K+ stimulated ATPase activity.
Prostaglandins Med. 1979 Aug;3(2):81-93. doi: 10.1016/0161-4630(79)90075-2.
9
Enhanced thromboxane B2 release from challenged guinea pig lung after oxygen exposure.氧气暴露后,受刺激的豚鼠肺中血栓素B2释放增强。
Am Rev Respir Dis. 1980 Apr;121(4):695-9. doi: 10.1164/arrd.1980.121.4.695.
10
Inhibitory effects of a novel platelet activating factor (PAF) antagonist (BN 52021) on antigen-induced prostaglandin and thromboxane formation by the guinea pig lung.一种新型血小板活化因子(PAF)拮抗剂(BN 52021)对豚鼠肺脏抗原诱导的前列腺素和血栓素形成的抑制作用。
Pharmacol Res Commun. 1986 Aug;18 Suppl:111-7. doi: 10.1016/0031-6989(86)90043-3.

引用本文的文献

1
Stimulating effect of thromboxane B2 on isolated rat atria.血栓素B2对离体大鼠心房的刺激作用。
Experientia. 1981 Jun;37(6):592-3. doi: 10.1007/BF01990068.
2
Tromboxane B2 inhibits the pulmonary inactivation of prostaglandin E2 in the dog.血栓素B2抑制犬体内前列腺素E2的肺部失活。
Br J Pharmacol. 1980 Oct;70(2):295-9. doi: 10.1111/j.1476-5381.1980.tb07935.x.